Skip to main content
    B

    BioCryst Pharmaceuticals Inc (BCRX)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $7.45
    -0.16 (-2.10%)

    Market Cap: $1.96B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    BioCryst Pharmaceuticals Inc (BCRX) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to BioCryst Pharmaceuticals are Supernus Pharmaceuticals (SUPN), Pacira BioSciences (PCRX) and Cronos Group (CRON). BioCryst Pharmaceuticals trades at 4.4x earnings, against a median of 10.7x. By market cap, BioCryst Pharmaceuticals ranks 5th of the 13 companies on this page; Bausch Health Companies (BHC) is the largest at $3.13B.

    Peer Comparison

    BCRX's ROIC of 24937.1% is above the peer median of 8.0%, and its revenue growth of 13.1% is above the median of 9.3%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    BioCryst Pharmaceuticals (BCRX)$1.96B4.4x2.0x-37.4%24937.1%13.1%0.00%
    Supernus Pharmaceuticals, Inc. (SUPN)$1.52B12.7x2.0x32.8%N/A13.4%0.00%
    Pacira BioSciences, Inc. (PCRX)$1.46B20.0x2.0x5.1%4.2%-1.6%0.00%
    Cronos Group Inc (CRON)$1.24B28.4x5.6x28.0%N/A74.6%0.00%
    Phibro Animal Health Corporation (PAHC)$1.46B10.7x0.9x6.7%11.7%6.3%1.37%
    Eton Pharmaceuticals Inc (ETON)$1.84B36.7x13.0x35.3%37.0%157.9%0.00%
    Amphastar P (AMPH)$1.25B10.3x1.7x13.3%7.9%8.2%0.00%
    Prestige Brand Holdings Inc (PBH)$2.19B10.7x2.0x13.3%5.0%22.7%0.00%
    Xeris Pharmaceuticals Inc (XERS)$3.04B139.2x8.2x-1.8%15.5%44.2%0.00%
    Bausch Health Companies Inc (BHC)$3.13B1.7x0.3x-7.6%6.3%9.7%0.00%
    Collegium Pharmaceutical Inc (COLL)$786.83M3.7x1.0x4.7%8.1%3.3%0.00%
    Perrigo Company PLC (PRGO)$2.25B7.0x0.6x-43.3%-26.3%-5.2%7.17%
    Ironwood Pharmaceuticals Inc (IRWD)$799.61M5.4x2.0x37.4%70.5%9.0%0.00%
    Peer median$1.49B10.7x2.0x10.0%8.0%9.3%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to BioCryst Pharmaceuticals, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - Specialty & Generic.

    CompanyAboutPeers
    Supernus Pharmaceuticals, Inc. (SUPN)
    Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of diseases...
    SUPN competitors
    Pacira BioSciences, Inc. (PCRX)
    Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare professionals and their patients in the United...
    PCRX competitors
    Cronos Group Inc (CRON)
    Cronos Group Inc. is a cannabinoid company. The company is headquartered in Toronto, Canada.
    CRON competitors
    Phibro Animal Health Corporation (PAHC)
    Phibro Animal Health Corporation develops, manufactures and supplies a range of mineral nutrition and animal health products for livestock primarily...
    PAHC competitors
    Eton Pharmaceuticals Inc (ETON)
    Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and marketing pharmaceuticals for rare diseases.
    ETON competitors
    Amphastar P (AMPH)
    Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation...
    AMPH competitors
    Prestige Brand Holdings Inc (PBH)
    Prestige Consumer Healthcare Inc., develops, manufactures, markets, distributes and sells over-the-counter (OTC) healthcare products in the United States...
    PBH competitors
    Xeris Pharmaceuticals Inc (XERS)
    Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets ready-to-use injectable and infusible drug formulations.
    XERS competitors
    Bausch Health Companies Inc (BHC)
    Bausch Health Companies Inc. develops, manufactures and markets a range of pharmaceutical...
    BHC competitors
    Collegium Pharmaceutical Inc (COLL)
    Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and markets pain management medications.
    COLL competitors
    Perrigo Company PLC (PRGO)
    Perrigo Company plc is an American Irish registered manufacturer of private label over-the-counter pharmaceuticals.
    PRGO competitors
    Ironwood Pharmaceuticals Inc (IRWD)
    Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products.
    IRWD competitors

    Frequently Asked Questions About BCRX

    Who are BioCryst Pharmaceuticals' main competitors?

    The companies most similar to BioCryst Pharmaceuticals include Supernus Pharmaceuticals (SUPN), Pacira BioSciences (PCRX), Cronos Group (CRON), Phibro Animal Health (PAHC) and Eton Pharmaceuticals (ETON), listed from the closest match.

    Who is BioCryst Pharmaceuticals' biggest competitor?

    Bausch Health Companies (BHC) is the largest of the similar companies at $3.13B; Supernus Pharmaceuticals (SUPN) is the closest match by business profile, size, sector and industry.

    How does BCRX stock compare with its competitors?

    BCRX's P/E is 4.4x against a peer median of 10.7x; its P/S is 2.0x against a peer median of 2.0x; its net margin is -37.4% against a peer median of 10.0%.

    Which of BioCryst Pharmaceuticals' competitors pays a higher dividend?

    BioCryst Pharmaceuticals pays no dividend. Perrigo Company (PRGO) and Phibro Animal Health (PAHC) have higher forward dividend yields; Perrigo Company (PRGO) has the highest at 7.17%.

    Is BioCryst Pharmaceuticals bigger than its competitors?

    No. BioCryst Pharmaceuticals is 5th by market cap among the 13 companies on this page; the largest is Bausch Health Companies (BHC) at $3.13B.